Data / Form D filings / RECOMBINETICS, INC
RECOMBINETICS, INC: Form D filings
RECOMBINETICS, INC, a biotechnology company in St. Paul, MN, filed 13 Form D notices with the SEC between 2013 and 2019. The latest, on February 1, 2019, reports $7.7 million sold of a $27.6 million offering to 11 investors.
Find out what RECOMBINETICS, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1246 University Avenue West, SUITE 301, St. Paul, MN, 55104
- Phone
- (612) 727-2000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Minnesota
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1543926
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | Amendment | $27,604,001 | $7,684,275 | $19,919,726 | 11 | Oct 20, 2016 | sec.gov |
| Sep 18, 2018 | New notice | $33,510,969 | $33,510,969 | $0 | 14 | Aug 20, 2018 | sec.gov |
| Mar 8, 2018 | Amendment | $18,150,000 | $6,361,560 | $11,788,440 | 47 | Sep 14, 2017 | sec.gov |
| Jan 11, 2018 | Amendment | $27,604,001 | $7,684,275 | $19,919,726 | 11 | Oct 20, 2016 | sec.gov |
| Jan 10, 2018 | Amendment | $18,150,000 | $2,141,151 | $16,008,849 | 35 | Sep 14, 2017 | sec.gov |
| Oct 2, 2017 | New notice | $18,150,000 | $82,500 | $18,067,500 | 1 | Sep 22, 2017 | sec.gov |
| Apr 27, 2017 | New notice | $8,268,750 | $6,982,500 | $1,286,250 | 10 | Feb 14, 2017 | sec.gov |
| Aug 23, 2016 | New notice | $3,688,820 | $630,000 | $3,058,820 | 7 | Jul 27, 2016 | sec.gov |
| Jul 8, 2016 | Amendment | $10,000,000 | $5,663,165 | $4,336,835 | 89 | Jun 26, 2015 | sec.gov |
| Nov 20, 2015 | New notice | $10,000,000 | $2,770,250 | $7,229,750 | 54 | Jun 25, 2015 | sec.gov |
| Oct 30, 2014 | New notice | $3,000,000 | $540,800 | $2,459,200 | 25 | Aug 11, 2014 | sec.gov |
| Aug 6, 2013 | New notice | $4,000,000 | $35,000 | $3,965,000 | 125 | Jul 22, 2013 | sec.gov |
| Mar 14, 2013 | New notice | $2,000,000 | $330,000 | $1,670,000 | 13 | Mar 1, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Justin F. Zenanko | Director | |
| Scott C. Fahrenkrug, Ph.D. | Director, Promoter | |
| John C. Burtis | Executive Officer | |
| Tammy Lee | Executive Officer | |
| Mitchell Abrahamsen, Ph.D. | Executive Officer | |
| Daniel F. Carlson, Ph.D. | Executive Officer | |
| Bill C. Farrell | Director | |
| Jerry C. Arndt | Director | |
| Jim C. Kilman | Director | |
| Peter C. Hajas | Director | |
| Scott C. Rathgaber | Director | |
| David F. Aberle | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jan 28, 2019 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RECOMBINETICS, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.